BeOne Medicines (ONC) Non Operating Income: 2016-2025
Historic Non Operating Income for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to -$19.0 million.
- BeOne Medicines' Non Operating Income fell 267.69% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.6 million, marking a year-over-year decrease of 215.42%. This contributed to the annual value of -$12.6 million for FY2024, which is 104.10% down from last year.
- According to the latest figures from Q3 2025, BeOne Medicines' Non Operating Income is -$19.0 million, which was down 332.39% from $8.2 million recorded in Q2 2025.
- BeOne Medicines' Non Operating Income's 5-year high stood at $336.7 million during Q3 2023, with a 5-year trough of -$800.2 million in Q4 2021.
- For the 3-year period, BeOne Medicines' Non Operating Income averaged around $26.2 million, with its median value being $4.0 million (2025).
- In the last 5 years, BeOne Medicines' Non Operating Income surged by 451.16% in 2021 and then plummeted by 14,850.06% in 2022.
- BeOne Medicines' Non Operating Income (Quarterly) stood at -$800.2 million in 2021, then skyrocketed by 102.43% to $19.4 million in 2022, then fell by 13.83% to $16.7 million in 2023, then slumped by 182.00% to -$13.7 million in 2024, then plummeted by 267.69% to -$19.0 million in 2025.
- Its Non Operating Income stands at -$19.0 million for Q3 2025, versus $8.2 million for Q2 2025 and $4.0 million for Q1 2025.